Connect with us

Health

Why Is Ampio Pharmaceuticals Inc (NYSEMKT:AMPE) In Focus?

Published

on

Ampio Pharmaceuticals Inc (NYSEMKT:AMPE) reported that the company will be featured as a presenting entity at the upcoming Annual Rodman & Renshaw Global Investment Event. This conference is being planned on September 10 to September 12, 2017 in New York City. Tom Chilcott, the CFO, and Holli Cherevka, the VP of Operations will offer an overview of the firm’s business during the presentation planned September 12, 2017. Management will be meeting with associates of the investment community during the event.

The buzz

In unrelated news, Ampio Pharmaceuticals reported that on September 1, 2017, it was informed by the NYSE American that the firm was not in compliance with certain of its continued listing guidelines as set forth in Part 10 of the “Company Guide”. To maintain its NYSE listing, the Exchange has asked that the firm should submit a plan of compliance by October 2, 2017, addressing how it plans to reclaim compliance by March 1, 2019. The management anticipates to submit a plan by the stated due date.

Receipt of the notification doesn’t have any immediate impact on the listing of the firm’s shares on the Exchange, barring that until the firm regains compliance with the NYSE Exchange’s listing guidelines, a “BC” indicator will be fixed to the firm’s trading ticker.

Ampio’s business operations, debt instruments and SEC reporting requirements are not affected by the notification, given that if the plan is not acceptable, or the firm fails to make sufficient development under the Plan or regain compliance by March 1, 2019, then the firm will be subject to the NYSE Exchange’s delisting guidelines.

The firm may then appeal a staff determination to start such proceedings as per the “Company Guide”. Ampio is a development stage biopharmaceutical entity primarily focused on the advancement of therapies to cure prevalent inflammatory ailments for which there are limited treatment alternatives.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of MMJReporter.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS
Advertisement

Symbol        Alert        High        Gain

 

  VBIO          $0.67       $4.10      500%

  IMLFF        $0.11       $0.57      400%

  CMXC        $0.25       $0.45      80%

  REPCF       $0.54       $0.79      48%

 

Get Your Latest Winner Delivered to Your Inbox!

FREE

For The Next 48 Hours

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement